Search details
1.
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases.
Breast Cancer Res Treat
; 193(3): 613-623, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35460498
2.
Measuring Ovarian Escape in Premenopausal Estrogen Receptor-Positive Breast Cancer Patients on Ovarian Suppression Therapy.
Oncologist
; 26(6): e936-e942, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33594769
3.
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer.
Breast Cancer Res Treat
; 188(2): 433-439, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33860388
4.
The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast.
Rep Pract Oncol Radiother
; 26(2): 179-187, 2021.
Article
in English
| MEDLINE | ID: mdl-34211767
5.
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia.
Breast Cancer Res Treat
; 177(2): 427-435, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31218477
6.
Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia.
Curr Oncol Rep
; 21(6): 51, 2019 04 17.
Article
in English
| MEDLINE | ID: mdl-30997616
7.
Omission of radiation therapy following breast conservation in older (≥70 years) women with T1-2N0 triple-negative breast cancer.
Breast J
; 25(6): 1126-1133, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31273872
8.
Retrospective review of genomic testing in breast cancer: Does it improve outcome?
Breast Cancer Res Treat
; 163(1): 191-195, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28224382
9.
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
JAMA
; 317(6): 596-605, 2017 02 14.
Article
in English
| MEDLINE | ID: mdl-28196254
10.
Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy.
Breast Cancer Res Treat
; 157(2): 203-210, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27178335
11.
A phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancer.
Oncologist
; 20(1): 13, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25378456
12.
The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis.
Breast Cancer Res Treat
; 153(3): 591-7, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26337685
13.
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.
Clin Cancer Res
; 28(20): 4392-4401, 2022 10 14.
Article
in English
| MEDLINE | ID: mdl-35877117
14.
Lactadherin and clearance of platelet-derived microvesicles.
Blood
; 113(6): 1332-9, 2009 Feb 05.
Article
in English
| MEDLINE | ID: mdl-19023116
15.
Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration: Case Series and Review of Literature.
Cureus
; 13(12): e20203, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-35004023
16.
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer.
Clin Breast Cancer
; 21(3): 199-204, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34159901
17.
Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy.
Sci Rep
; 11(1): 82, 2021 01 08.
Article
in English
| MEDLINE | ID: mdl-33420229
18.
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.
Sci Transl Med
; 13(624): eabj5070, 2021 12 15.
Article
in English
| MEDLINE | ID: mdl-34910551
19.
Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data.
ERJ Open Res
; 6(2)2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32714960
20.
Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
Breast
; 49: 8-16, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31675684